National Health Investors Statistics
Share Statistics
National Health Investors has 45.42M shares outstanding. The number of shares has increased by 5.63% in one year.
| Shares Outstanding | 45.42M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 5.6% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 43.29M |
| Failed to Deliver (FTD) Shares | 32 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 1.35M, so 2.97% of the outstanding shares have been sold short.
| Short Interest | 1.35M |
| Short % of Shares Out | 2.97% |
| Short % of Float | 3.11% |
| Short Ratio (days to cover) | 5.4 |
Valuation Ratios
The PE ratio is 17.86 and the forward PE ratio is 25.56. National Health Investors 's PEG ratio is 6.99.
| PE Ratio | 17.86 |
| Forward PE | 25.56 |
| PS Ratio | 7.58 |
| Forward PS | 9.4 |
| PB Ratio | 1.93 |
| P/FCF Ratio | 13.41 |
| PEG Ratio | 6.99 |
Enterprise Valuation
National Health Investors Inc. has an Enterprise Value (EV) of 3.54B.
| EV / Earnings | 26.07 |
| EV / Sales | 11.06 |
| EV / EBITDA | 14.06 |
| EV / EBIT | 19.78 |
| EV / FCF | 19.57 |
Financial Position
The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.91.
| Current Ratio | 2.37 |
| Quick Ratio | 2.37 |
| Debt / Equity | 0.91 |
| Total Debt / Capitalization | 47.51 |
| Cash Flow / Debt | 0.16 |
| Interest Coverage | 3.22 |
Financial Efficiency
Return on equity (ROE) is 0.11% and return on capital (ROIC) is 7.42%.
| Return on Equity (ROE) | 0.11% |
| Return on Assets (ROA) | 0.05% |
| Return on Capital (ROIC) | 7.42% |
| Revenue Per Employee | 12.30M |
| Profits Per Employee | 5.22M |
| Employee Count | 26 |
| Asset Turnover | 0.13 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 29.19% in the last 52 weeks. The beta is 1.07, so National Health Investors 's price volatility has been higher than the market average.
| Beta | 1.07 |
| 52-Week Price Change | 29.19% |
| 50-Day Moving Average | 77.27 |
| 200-Day Moving Average | 71.31 |
| Relative Strength Index (RSI) | 26.7 |
| Average Volume (20 Days) | 260.00K |
Income Statement
In the last 12 months, National Health Investors had revenue of $319.83M and earned $135.65M in profits. Earnings per share was $3.13.
| Revenue | 319.83M |
| Gross Profit | 308.32M |
| Operating Income | 178.79M |
| Net Income | 135.65M |
| EBITDA | 251.49M |
| EBIT | 178.79M |
| Earnings Per Share (EPS) | 3.13 |
Balance Sheet
The company has $22.35M in cash and $1.14B in debt, giving a net cash position of -$1.11B.
| Cash & Cash Equivalents | 22.35M |
| Total Debt | 1.14B |
| Net Cash | -1.11B |
| Retained Earnings | 2.47B |
| Total Assets | 2.46B |
| Working Capital | 329.82M |
Cash Flow
In the last 12 months, operating cash flow was $184.45M and capital expenditures -$3.74M, giving a free cash flow of $180.71M.
| Operating Cash Flow | 184.45M |
| Capital Expenditures | -3.74M |
| Free Cash Flow | 180.71M |
| FCF Per Share | 4.16 |
Margins
Gross margin is 96.4%, with operating and profit margins of 55.9% and 42.41%.
| Gross Margin | 96.4% |
| Operating Margin | 55.9% |
| Pretax Margin | 42.02% |
| Profit Margin | 42.41% |
| EBITDA Margin | 78.63% |
| EBIT Margin | 55.9% |
| FCF Margin | 56.5% |
Dividends & Yields
NHI pays an annual dividend of $3.6, which amounts to a dividend yield of 4.98%.
| Dividend Per Share | $3.60 |
| Dividend Yield | 4.98% |
| Dividend Growth (YoY) | 0% |
| Payout Ratio | 123.71% |
| Earnings Yield | 4.31% |
| FCF Yield | 5.48% |
Analyst Forecast
The average price target for NHI is $73.5, which is 1.2% higher than the current price. The consensus rating is "Buy".
| Price Target | $73.5 |
| Price Target Difference | 1.2% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
Scores
| Altman Z-Score | 3.63 |
| Piotroski F-Score | 7 |